This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4kfp
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived Ureas as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)== | ==Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived Ureas as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)== | ||
| - | <StructureSection load='4kfp' size='340' side='right' caption='[[4kfp]], [[Resolution|resolution]] 1.84Å' scene=''> | + | <StructureSection load='4kfp' size='340' side='right'caption='[[4kfp]], [[Resolution|resolution]] 1.84Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4kfp]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4kfp]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4KFP OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4KFP FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1R7:N-(4-{[1-(TETRAHYDRO-2H-PYRAN-4-YL)PIPERIDIN-4-YL]SULFONYL}BENZYL)-2H-PYRROLO[3,4-C]PYRIDINE-2-CARBOXAMIDE'>1R7</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1R7:N-(4-{[1-(TETRAHYDRO-2H-PYRAN-4-YL)PIPERIDIN-4-YL]SULFONYL}BENZYL)-2H-PYRROLO[3,4-C]PYRIDINE-2-CARBOXAMIDE'>1R7</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4kfp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4kfp OCA], [https://pdbe.org/4kfp PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4kfp RCSB], [https://www.ebi.ac.uk/pdbsum/4kfp PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4kfp ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity). |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 22: | Line 20: | ||
==See Also== | ==See Also== | ||
| - | *[[Phosphoribosyltransferase|Phosphoribosyltransferase]] | + | *[[Phosphoribosyltransferase 3D structures|Phosphoribosyltransferase 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Bair | + | [[Category: Bair KW]] |
| - | [[Category: Baumeister | + | [[Category: Baumeister T]] |
| - | [[Category: | + | [[Category: Dragovich PS]] |
| - | [[Category: | + | [[Category: Ho Y]] |
| - | [[Category: | + | [[Category: Liederer BM]] |
| - | [[Category: | + | [[Category: Liu X]] |
| - | [[Category: | + | [[Category: O'Brien T]] |
| - | [[Category: Oeh | + | [[Category: Oeh J]] |
| - | [[Category: Sampath | + | [[Category: Sampath D]] |
| - | [[Category: Skelton | + | [[Category: Skelton N]] |
| - | [[Category: Wang | + | [[Category: Wang L]] |
| - | [[Category: Wang | + | [[Category: Wang W]] |
| - | [[Category: Wu | + | [[Category: Wu H]] |
| - | [[Category: Xiao | + | [[Category: Xiao Y]] |
| - | [[Category: Yuen | + | [[Category: Yuen P]] |
| - | [[Category: Zak | + | [[Category: Zak M]] |
| - | [[Category: Zhang | + | [[Category: Zhang L]] |
| - | [[Category: Zheng | + | [[Category: Zheng X]] |
| - | + | ||
Revision as of 11:56, 30 November 2022
Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived Ureas as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)
| |||||||||||
Categories: Homo sapiens | Large Structures | Bair KW | Baumeister T | Dragovich PS | Ho Y | Liederer BM | Liu X | O'Brien T | Oeh J | Sampath D | Skelton N | Wang L | Wang W | Wu H | Xiao Y | Yuen P | Zak M | Zhang L | Zheng X
